ACRX - アセルRX・ファ―マシュ―ティカルズ (AcelRx Pharmaceuticals Inc.)

ACRXのニュース

   AcelRx to Host Fourth Quarter and Full Year 2021 Financial Results Call and Webcast on March 10, 2022  2022/03/03 21:05:00 PR Newswire
HAYWARD, Calif., March 3, 2022 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company, today announced that it will release fourth quarter financial results after market close on Thursday, March 10, 2022. AcelRx management will host a live webcast…
   AcelRx announces data on pain drug sufentanil sublingual for use in awake plastic surgery  2022/02/01 20:39:22 Seeking Alpha
AcelRx Pharmaceuticals (ACRX) announced real-world data for sufentanil sublingual tablet ((SST)) for pain management in patients undergoing awake plastic surgery showing a rapid…
   AcelRx Pharmaceuticals: The Fog Is Getting Thicker  2022/01/14 09:10:25 Seeking Alpha
   Volume Buzz: AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), AbbVie Inc. (NYSE:ABBV)  2021/12/14 23:41:09 Stock Equity
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) with the stream of -3.03% also noticed, India AbbVie Inc. (NYSE:ABBV) encountered a rapid change of 0.62% in the last hour of Tuesdays trading session. AcelRx The post Volume Buzz: AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), AbbVie Inc. (NYSE:ABBV) appeared first on Stocks Equity .
   AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Position Lowered by Goldman Sachs Group Inc.  2021/12/13 09:08:42 Dakota Financial News
Goldman Sachs Group Inc. decreased its stake in shares of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) by 45.8% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 107,938 shares of the specialty pharmaceutical companys stock after selling 91,266 shares during the period. Goldman Sachs Group Inc.s holdings in []
   Volume Buzz: AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), AbbVie Inc. (NYSE:ABBV)  2021/12/14 23:41:09 Stock Equity
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) with the stream of -3.03% also noticed, India AbbVie Inc. (NYSE:ABBV) encountered a rapid change of 0.62% in the last hour of Tuesdays trading session. AcelRx The post Volume Buzz: AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), AbbVie Inc. (NYSE:ABBV) appeared first on Stocks Equity .
   AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Position Lowered by Goldman Sachs Group Inc.  2021/12/13 09:08:42 Dakota Financial News
Goldman Sachs Group Inc. decreased its stake in shares of AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) by 45.8% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 107,938 shares of the specialty pharmaceutical companys stock after selling 91,266 shares during the period. Goldman Sachs Group Inc.s holdings in []
   Bright Stock Buzz: AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), New Gold Inc. (AMEX:NGD)  2021/12/13 00:34:59 Stock Equity
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) with the stream of -2.17% also noticed, India New Gold Inc. (AMEX:NGD) encountered a rapid change of -2.76% in the last hour of Fridays trading session. The post Bright Stock Buzz: AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), New Gold Inc. (AMEX:NGD) appeared first on Stocks Equity .
   Blustering Stock: Vonage Holdings Corp. (NASDAQ:VG), AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)  2021/12/04 09:56:52 Stock Equity
Vonage Holdings Corp. (VG) with the stream of 0.58% also noticed, India AcelRx Pharmaceuticals, Inc. (ACRX) encountered a rapid change of -5.81% in the last hour of Fridays trading session. The post Blustering Stock: Vonage Holdings Corp. (NASDAQ:VG), AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) appeared first on Stocks Equity .
   AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Holdings Raised by Millennium Management LLC  2021/12/04 09:56:42 Transcript Daily
Millennium Management LLC boosted its stake in AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) by 21.9% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,516,715 shares of the specialty pharmaceutical companys stock after buying an additional 272,974 shares during the quarter. Millennium Management []
   Blustering Stock: Vonage Holdings Corp. (NASDAQ:VG), AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX)  2021/12/04 09:56:52 Stock Equity
Vonage Holdings Corp. (VG) with the stream of 0.58% also noticed, India AcelRx Pharmaceuticals, Inc. (ACRX) encountered a rapid change of -5.81% in the last hour of Fridays trading session. The post Blustering Stock: Vonage Holdings Corp. (NASDAQ:VG), AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) appeared first on Stocks Equity .
   AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Holdings Raised by Millennium Management LLC  2021/12/04 09:56:42 Transcript Daily
Millennium Management LLC boosted its stake in AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) by 21.9% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,516,715 shares of the specialty pharmaceutical companys stock after buying an additional 272,974 shares during the quarter. Millennium Management []
   Bright Stock in Review: AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), Alpha Pro Tech, Ltd. (AMEX:APT)  2021/11/29 03:59:21 Stock Equity
AcelRx Pharmaceuticals, Inc. (ACRX) with the stream of -3.66% also noticed, India Alpha Pro Tech, Ltd. (APT) encountered a rapid change of 25.20% in the last hour of trading session. The post Bright Stock in Review: AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), Alpha Pro Tech, Ltd. (AMEX:APT) appeared first on Stocks Equity .
   Acelrx Pharmaceuticals Inc Shares Approach 52-Week Low - Market Mover  2021/11/27 02:32:18 Kwhen Finance
Acelrx Pharmaceuticals Inc (ACRX) shares closed today at 0.3% above its 52 week low of $0.65, giving the company a market cap of $80M. The stock is currently down 45.4% year-to-date, down 56.0% over the past 12 months, and down 77.8% over the past five years. This week, the Dow Jones Industrial Average fell 0.2%, and the S&P 500 fell 0.1%. Trading Activity Trading volume this week was 43.4% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 35.4% The company's stock price performance over the past 12 months lags the peer average by 107.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   AcelRx Pharmaceuticals Announces the Appointment of Jill Broadfoot to its Board of Directors  2021/11/23 22:09:00 PR Newswire
HAYWARD, Calif., Nov. 23, 2021 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced the appointment of Jill

calendar